A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Tech, non-tech sectors mixed on recommended carbon fees
10/07/2024 11:10 PM - Business
Taiwan's recommended carbon fee too low: Environmental groups
10/07/2024 11:02 PM - Science & Tech
New study finds 'adequate' fruit, vegetable diet can boost life expectancy
10/07/2024 10:30 PM - Politics
Tai Tzu-ying becomes Taiwan's youngest ambassador-at-large
10/07/2024 10:15 PM - Society
No major losses for Taiwanese companies from recent cyberattacks: MODA
10/07/2024 09:31 PM